Skip to content

Exploration of eJaculatory Anatomy Concept Study (EJAC Study)

Study of the Biomechanical Anatomy of Ejaculation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05650853
Enrollment
3
Registered
2022-12-14
Start date
2022-12-12
Completion date
2023-01-09
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ejaculatory Dysfunction

Brief summary

Ejaculatory dysfunctions (ED) are an important cause of postoperative dissatisfaction, which lead to a decrease in the intensity of orgasms in 50% of patients. ED is a cause for concern for almost a third of patients who need surgery. Surgical techniques have been developed to limit the occurrence of postoperative ED, but their results remain heterogeneous. There are very few studies on the biomechanical anatomy of ejaculation. Ejaculation is a complex phenomenon involving different structures and in particular the Veru Montanum. This is the key element in the emission of ejaculate within the prostatic urethra. In addition, there is a structure located in the resection zone of the prostate adenoma. It has therefore been suggested that its resection was a primary source of ED. A single observational study carried out in by Gil Vernet et al in 1994 evaluated on a single healthy 18-year-old volunteer the ejaculatory mechanism of expulsion using an endorectal probe recording the movements of the prostate, the bladder neck and of the proximal urethra during ejaculation. A contemporary study of the biomechanics of the ejaculatory expulsion phase could confirm and improve understanding of the involvement of anatomical structures. The results of our study aim to adapt surgical techniques aimed at limiting the risk of postoperative ED.

Interventions

Examinations for observation of the pre, per and post-ejaculatory phases

OTHERUrethroscopy

Examinations for observation of the pre, per and post-ejaculatory phases

Sponsors

Clinique Pasteur
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Affiliated subject or beneficiary of a social security scheme * Subject agreeing to participate and having signed the free, informed consent.

Exclusion criteria

* Subject with ejaculatory dysfunction * Subject with urinary dysfunction * History of urinary or penile surgery * Subject with untreated urinary tract infection * History of chronic prostatitis * Pathology making it impossible to introduce the endorectal probe or the ureteroscope * History of colorectal inflammatory disease * Recent intake (within 30 days) of drugs known to interfere with ejaculation * History of intolerance or allergy to any of the drugs used in the study * Subject participating in another clinical study * Adults under guardianship, curatorship or other legal protection; deprived of liberty by judicial or administrative decision; Hospitalized without consent.

Design outcomes

Primary

MeasureTime frameDescription
Peri-urethral muscle contractionAt Day 0Qualitative description of peri-urethral muscle contraction according to ultrasound videos analysis
Urethra, bladder neck and prostate movementsAt Day 0Qualitative description of movements of the urethra, bladder neck and prostate according to ultrasound videos analysis
Sperm flow within the prostatic urethraAt Day 0Qualitative description of sperm flow within the prostatic urethra according to ultrasound videos analysis
Spermatic fluid via the ejaculatory ductsAt Day 6Qualitative description of the expulsion and flow of spermatic fluid via the ejaculatory ducts according to urethroscopy videos analysis
Veru montanum mobility and urethral contraction.At Day 6Qualitative description of veru montanum mobility and urethral contraction according to urethroscopy videos analysis

Countries

France

Contacts

STUDY_DIRECTORBenjamin Pradère, MD

Clinique La Croix du Sud

STUDY_DIRECTOREric Bruguière, MD

Clinique Pasteur

STUDY_DIRECTORVincent Misraï, MD

Clinique Pasteur

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026